Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
VivaVision Biotech
company
About
VivaVision Biotech is a clinical-stage R&D biopharmaceutical company.
- 1 - 10
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ¥65M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥365M
VivaVision Biotech has raised a total of
¥365M
in funding over 2 rounds. Their latest funding was raised on
Apr 21, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 21, 2021 | Series D | ¥300M | 4 | — | — | Detail |
| Sep 26, 2019 | Series C | ¥65M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
6
VivaVision Biotech is funded by 6 investors.
CFS Capital
and FengHe Fund Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
FengHe Fund Management
|
— | Series D |
|
|
— | Series D |
|
|
— | Series D |
|
|
— | Series C |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
